CVM

CEL SCI CORP

Biological Products, (No Diagnostic Substances)NYSENon-accelerated filer<br>Smaller reporting company

Total Trades

4

Buys

4

Sells

0

Largest Trade

$100K–$500K

Insiders

2

Institutional Funds

32

Inst. Value

$1M+

Activist Filings

5

Insider Trades

InsiderTitleTypeValueSharesPriceDate
KERSTEN GEERT RCEOBUY$100K–$500K38K$5.26Jan 26, 2026
KERSTEN GEERT RCEOBUY$15K–$50K8K$5.96Dec 5, 2025
Watson Robert EugeneDirectorBUY$15K–$50K3K$6.85Jul 29, 2025
KERSTEN GEERT RCEOBUY$100K–$500K29K$6.85Jul 28, 2025
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 32 funds holding

FundShares
MAI Capital Management90K
GEODE CAPITAL MANAGEMENT, LLC64K
VANGUARD GROUP INC49K
BlackRock, Inc.43K
STATE STREET CORP26K
COMMONWEALTH EQUITY SERVICES, LLC22K
US BANCORP \DE\18K
JANE STREET GROUP, LLC16K
RENAISSANCE TECHNOLOGIES LLC15K
HRT FINANCIAL LP12K
HighTower Advisors, LLC10K
CHILTON CAPITAL MANAGEMENT LLC5K
Archer Investment Corp2K
WELLS FARGO & COMPANY/MN740
Steward Partners Investment Advisory, LLC686
Hilton Head Capital Partners, LLC450
UBS Group AG282
AdvisorNet Financial, Inc97
Fortitude Family Office, LLC75
MORGAN STANLEY58

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

6.9%

555K shares

BlackRock, Inc.

SC 13G · Jul 8, 2022

2.7%

1.2M shares

BlackRock, Inc.

SC 13G/A · Jan 31, 2022

6.8%

2.9M shares

View on Google Finance →